Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Genalyte Teams with Scienion to Provide sciFLEXARRAYER Dispensers

Published: Thursday, September 20, 2012
Last Updated: Wednesday, September 19, 2012
Bookmark and Share
Scienion’s automated liquid handling dispenser complements the simplicity, speed and flexibility of the Maverick multiplexed system.

Genalyte, Inc. and Scienion AG have announced an agreement under which Genalyte will market Scienion’s sciFLEXARRAYER™ automated liquid dispensers along with Genalyte’s multiplexed Maverick™ Detection System.

The Maverick platform uses a proprietary silicon chip containing arrays of photonic micro ring sensors to simultaneously analyze multiple proteins, DNA or biomarkers from a single small sample, using a one-step process that automates the washes, incubations, reagents and processing steps associated with other technologies.

Scienion’s sciFLEXARRAYERs are automated, non-contact dispensing systems for ultra-low volume liquid handling of biological samples.

Genalyte is offering customers the sciFLEXARRAYER S5, a robust production unit designed for low maintenance, long term use as a flexible and dependable tool for manufacturing high quality arrays.

Its integrated dispense control and auto-drop function provide users with an easy-to-use, walk-away solution for a variety of liquid dispensing applications.

“After a rigorous search for an automated liquid dispensing system with the precision needed to spot sample material onto the Maverick system’s 30-micron rings, I am pleased to announce this agreement with Scienion,” said Cary Gunn, PhD, CEO of Genalyte.

Gunn continued, “The company’s dependable, ultra low volume liquid handling dispensers allow for highly precise, contact-free drop spotting and are well suited for microarray based applications. We now can offer our customers a comprehensive validated automated system for multiplexed detection and analysis.”

Under the terms of the agreement, Genalyte will market the sciFLEXARRAYER S5 dispenser to its customers and Scienion will retain responsibility for installing and servicing the sciFLEXARRAYER.

Dr. Holger Eickhoff, CEO of Scienion AG, commented, “As a leading provider of advanced automated liquid dispensing systems, we welcome the opportunity to collaborate with multiplexing innovator Genalyte. We view our products as highly complementary and look forward to a productive partnership.”

Separately, Genalyte announced the launch of its Custom Spotting Service. To provide scientists with maximum flexibility to design multiplex assay panels addressing their specific research needs, Genalyte is now offering a cost effective custom spotting service that will load proteins such as antibodies, peptides, biomarkers, cytokines and antigens supplied by customers onto Genalyte chips.

The chips are then returned to the customer in the same ready-to-use chip array format used in Genalyte’s off-the shelf multiplex assay kits, ready to be run on the Maverick Detection System.

The Maverick multiplex system can deliver results from small samples of many types, including serum, plasma, culture media and whole blood. For more information, visit www.genalyte.com/products/custom-chip-spotting/.

The Maverick Detection System and its ENA 4 and ENA 6 Assay Kits are currently commercially available to researchers. The assays simultaneously screen for several of the most common auto antibodies found in autoimmune connective tissue disorders, such as systemic lupus erythematosus (SLE).

Assay kits for advanced SLE testing, rheumatoid arthritis and Type I diabetes are available under the Genalyte Technology Access program.

The simplified one-step workflow of the Maverick assays delivers accurate results in 15 minutes, and they can be run using very small volume samples from a variety of matrices, including serum and plasma.

Semi-quantitative results are reported for each analyte, eliminating the need for reflex testing. The Maverick platform has a large dynamic range and excellent sensitivity, with outstanding reproducibility.

For more information about Genalyte, the Maverick platform, the Maverick ENA 4 and ENA 6 Assay Kits, the Technology Access program and Genalyte’s Custom Chip Spotting Service, visit www.genalyte.com. Maverick assays are currently available for research use only.

The Lab-on-a-Chip World Congress will be held September 25-26, 2012 in San Diego, CA. Information about Scienion and Genalyte products will be available at Booth 26.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Molecular Detection of Colon Cancer
AIT, BioVendor and SCIENION signed cooperation agreement for early detection of colon cancer.
Saturday, September 27, 2014
SCIENION and Innopsys Agree on a Joint Product Offering for RPPA
Added value for customers combining technologies of both companies into a complete assay solution.
Tuesday, March 26, 2013
Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Less May Be More in Slowing Cholera Epidemics
Mathematical model shows more cases may be prevented and more lives saved when using one dose of cholera vaccine instead of recommended two doses.
Investigating the Vape
Expert independent review concludes that e-cigarettes have potential to help smokers quit.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Researchers Discover Synthesis of a New Nanomaterial
Interdisciplinary team creates biocomposite for first time using physiological conditions.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Flu Remedies Help Combat E. coli Bacteria
Physiologists from the University of Zurich have now discovered why the intestinal bacterium Escherichia coli (E. coli) multiplies heavily and has an inflammatory effect.
Marijuana Genome Unraveled
A study by Canadian researchers is providing a clearer picture of the evolutionary history and genetic organization of cannabis, a step that could have agricultural, medical and legal implications for this valuable crop.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!